SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Aug-22 5:36 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Aug-22 | Payment of Exercise | 7,257 | $38.02 | $275,911.00 | (10%) 75.0K to 67.74K | |
16-Aug-22 5:36 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Aug-22 | Option Exercise | 65,000 | $4.24 | $275,750.00 | 650% 10.0K to 75.0K | |
16-Aug-22 5:36 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Aug-22 | Option Sale | 57,743 | $38.31 | $2,211,980.00 | (85%) 67.74K to 10.0K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Payment of Exercise | 9,647 | $30.23 | $291,629.00 | (18%) 52.5K to 42.85K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Option Exercise | 42,500 | $6.86 | $291,400.00 | 425% 10.0K to 52.5K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Option Sale | 32,853 | $30.54 | $1,003,480.00 | (77%) 42.85K to 10.0K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Payment of Exercise | 6,685 | $31.42 | $210,043.00 | (19%) 35.0K to 28.32K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Option Exercise | 25,000 | $8.40 | $210,000.00 | 250% 10.0K to 35.0K | |
08-Mar-22 7:32 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Option Sale | 18,315 | $30.79 | $563,919.00 | (65%) 28.32K to 10.0K | |
17-Aug-17 5:33 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Aug-17 | Market Purchase | 10,000 | $2.48 | $24,824.00 | 100% 0 to 10.0K | 131% |